Open access
Aug 2026
OAF Blocks SIAH1‐Mediated Degradation of SCPX, a Therapeutic Strategy for MASLD
ABSTRACT Metabolic dysfunction‐associated steatotic liver disease (MASLD) poses an increasing threat to global public health. Currently approved drugs for MASLD, such as resmetirom and semaglutide, have demonstrated clinical efficacy. However, their use is associated with notable adverse effects, including serious gast...
Zong-Xi Li, Jing Song, Kai-Li Ma et al.
· Advancement of science · 0 citations